Displaying 25 - 36 of 50
Immune-Mediated and Cholestatic Diseases
Enhancing clinical care strategies in PBC

Enhancing clinical care strategies in PBC

Webcasts
View
Cirrhosis & Complications
Modulating systemic inflammation: how does Albumin work?

Modulating systemic inflammation: how does Albumin work?

Webcasts
View
Cirrhosis & Complications
How do patients benefit from Albumin?

How do patients benefit from Albumin?

Webcasts
View
Cirrhosis & Complications
Summary and Conclusions “from a fluid to a  medicine”

Summary and Conclusions “from a fluid to a  medicine”

Webcasts
View
Cirrhosis & Complications
The effective albumin concentration: from hypothesis to reality

The effective albumin concentration: from hypothesis to reality

Webcasts
View
Cirrhosis & Complications
Welcome and Introduction

Welcome and Introduction

Webcasts
View
Metabolism, Alcohol & Toxicity

The NASH care pathway: Drivers and emerging trends

Webcasts
View
Metabolism, Alcohol & Toxicity

How to optimise NASH patient care? – Collaboration with different specialities

Webcasts
View
Metabolism, Alcohol & Toxicity

How do non-invasive techniques improve patient identification and risk stratification?

Webcasts
View
Metabolism, Alcohol & Toxicity

Future improvements needed for care pathways for patients with NASH – Q&A

Webcasts
View
General Hepatology

Chair’s welcome

Webcasts
View
General Hepatology

New insights into the role of FXR agonism in PBC

Webcasts
View
Displaying 25 - 36 of 50